219 related articles for article (PubMed ID: 27732936)
1. The ETS factor ESE3/EHF represses IL-6 preventing STAT3 activation and expansion of the prostate cancer stem-like compartment.
Albino D; Civenni G; Rossi S; Mitra A; Catapano CV; Carbone GM
Oncotarget; 2016 Nov; 7(47):76756-76768. PubMed ID: 27732936
[TBL] [Abstract][Full Text] [Related]
2. ESE3/EHF controls epithelial cell differentiation and its loss leads to prostate tumors with mesenchymal and stem-like features.
Albino D; Longoni N; Curti L; Mello-Grand M; Pinton S; Civenni G; Thalmann G; D'Ambrosio G; Sarti M; Sessa F; Chiorino G; Catapano CV; Carbone GM
Cancer Res; 2012 Jun; 72(11):2889-900. PubMed ID: 22505649
[TBL] [Abstract][Full Text] [Related]
3. Activation of the Lin28/let-7 Axis by Loss of ESE3/EHF Promotes a Tumorigenic and Stem-like Phenotype in Prostate Cancer.
Albino D; Civenni G; Dallavalle C; Roos M; Jahns H; Curti L; Rossi S; Pinton S; D'Ambrosio G; Sessa F; Hall J; Catapano CV; Carbone GM
Cancer Res; 2016 Jun; 76(12):3629-43. PubMed ID: 27197175
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-424 impairs ubiquitination to activate STAT3 and promote prostate tumor progression.
Dallavalle C; Albino D; Civenni G; Merulla J; Ostano P; Mello-Grand M; Rossi S; Losa M; D'Ambrosio G; Sessa F; Thalmann GN; Garcia-Escudero R; Zitella A; Chiorino G; Catapano CV; Carbone GM
J Clin Invest; 2016 Dec; 126(12):4585-4602. PubMed ID: 27820701
[TBL] [Abstract][Full Text] [Related]
5. Aberrant expression of the neuronal-specific protein DCDC2 promotes malignant phenotypes and is associated with prostate cancer progression.
Longoni N; Kunderfranco P; Pellini S; Albino D; Mello-Grand M; Pinton S; D'Ambrosio G; Sarti M; Sessa F; Chiorino G; Catapano CV; Carbone GM
Oncogene; 2013 May; 32(18):2315-24, 2324.e1-4. PubMed ID: 22733135
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic regulation of CpG promoter methylation in invasive prostate cancer cells.
Mathews LA; Hurt EM; Zhang X; Farrar WL
Mol Cancer; 2010 Oct; 9():267. PubMed ID: 20929579
[TBL] [Abstract][Full Text] [Related]
7. EC-70124, a Novel Glycosylated Indolocarbazole Multikinase Inhibitor, Reverts Tumorigenic and Stem Cell Properties in Prostate Cancer by Inhibiting STAT3 and NF-κB.
Civenni G; Longoni N; Costales P; Dallavalle C; García Inclán C; Albino D; Nuñez LE; Morís F; Carbone GM; Catapano CV
Mol Cancer Ther; 2016 May; 15(5):806-18. PubMed ID: 26826115
[TBL] [Abstract][Full Text] [Related]
8. C/EBPdelta is a downstream mediator of IL-6 induced growth inhibition of prostate cancer cells.
Sanford DC; DeWille JW
Prostate; 2005 May; 63(2):143-54. PubMed ID: 15486993
[TBL] [Abstract][Full Text] [Related]
9. Epithelial-mesenchymal transition and cancer stem cells, mediated by a long non-coding RNA, HOTAIR, are involved in cell malignant transformation induced by cigarette smoke extract.
Liu Y; Luo F; Xu Y; Wang B; Zhao Y; Xu W; Shi L; Lu X; Liu Q
Toxicol Appl Pharmacol; 2015 Jan; 282(1):9-19. PubMed ID: 25447409
[TBL] [Abstract][Full Text] [Related]
10. Pharmacologic suppression of JAK1/2 by JAK1/2 inhibitor AZD1480 potently inhibits IL-6-induced experimental prostate cancer metastases formation.
Gu L; Talati P; Vogiatzi P; Romero-Weaver AL; Abdulghani J; Liao Z; Leiby B; Hoang DT; Mirtti T; Alanen K; Zinda M; Huszar D; Nevalainen MT
Mol Cancer Ther; 2014 May; 13(5):1246-58. PubMed ID: 24577942
[TBL] [Abstract][Full Text] [Related]
11. Coexpression of gene Oct4 and Nanog initiates stem cell characteristics in hepatocellular carcinoma and promotes epithelial-mesenchymal transition through activation of Stat3/Snail signaling.
Yin X; Zhang BH; Zheng SS; Gao DM; Qiu SJ; Wu WZ; Ren ZG
J Hematol Oncol; 2015 Mar; 8():23. PubMed ID: 25879771
[TBL] [Abstract][Full Text] [Related]
12. Aberrantly expressed Fra-1 by IL-6/STAT3 transactivation promotes colorectal cancer aggressiveness through epithelial-mesenchymal transition.
Liu H; Ren G; Wang T; Chen Y; Gong C; Bai Y; Wang B; Qi H; Shen J; Zhu L; Qian C; Lai M; Shao J
Carcinogenesis; 2015 Apr; 36(4):459-68. PubMed ID: 25750173
[TBL] [Abstract][Full Text] [Related]
13. KLF4, A Gene Regulating Prostate Stem Cell Homeostasis, Is a Barrier to Malignant Progression and Predictor of Good Prognosis in Prostate Cancer.
Xiong X; Schober M; Tassone E; Khodadadi-Jamayran A; Sastre-Perona A; Zhou H; Tsirigos A; Shen S; Chang M; Melamed J; Ossowski L; Wilson EL
Cell Rep; 2018 Dec; 25(11):3006-3020.e7. PubMed ID: 30540935
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of STAT3 signaling targets both tumor-initiating and differentiated cell populations in prostate cancer.
Han Z; Wang X; Ma L; Chen L; Xiao M; Huang L; Cao Y; Bai J; Ma D; Zhou J; Hong Z
Oncotarget; 2014 Sep; 5(18):8416-28. PubMed ID: 25261365
[TBL] [Abstract][Full Text] [Related]
15. Long noncoding RNA lncTCF7, induced by IL-6/STAT3 transactivation, promotes hepatocellular carcinoma aggressiveness through epithelial-mesenchymal transition.
Wu J; Zhang J; Shen B; Yin K; Xu J; Gao W; Zhang L
J Exp Clin Cancer Res; 2015 Oct; 34():116. PubMed ID: 26452542
[TBL] [Abstract][Full Text] [Related]
16. IL-6 promotes head and neck tumor metastasis by inducing epithelial-mesenchymal transition via the JAK-STAT3-SNAIL signaling pathway.
Yadav A; Kumar B; Datta J; Teknos TN; Kumar P
Mol Cancer Res; 2011 Dec; 9(12):1658-67. PubMed ID: 21976712
[TBL] [Abstract][Full Text] [Related]
17. ETS transcription factors control transcription of EZH2 and epigenetic silencing of the tumor suppressor gene Nkx3.1 in prostate cancer.
Kunderfranco P; Mello-Grand M; Cangemi R; Pellini S; Mensah A; Albertini V; Malek A; Chiorino G; Catapano CV; Carbone GM
PLoS One; 2010 May; 5(5):e10547. PubMed ID: 20479932
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA SNHG3, induced by IL-6/STAT3 transactivation, promotes stem cell-like properties of gastric cancer cells by regulating the miR-3619-5p/ARL2 axis.
Sun B; Han Y; Cai H; Huang H; Xuan Y
Cell Oncol (Dordr); 2021 Feb; 44(1):179-192. PubMed ID: 32930970
[TBL] [Abstract][Full Text] [Related]
19. Cancer-related inflammation and Barrett's carcinogenesis: interleukin-6 and STAT3 mediate apoptotic resistance in transformed Barrett's cells.
Zhang HY; Zhang Q; Zhang X; Yu C; Huo X; Cheng E; Wang DH; Spechler SJ; Souza RF
Am J Physiol Gastrointest Liver Physiol; 2011 Mar; 300(3):G454-60. PubMed ID: 21148399
[TBL] [Abstract][Full Text] [Related]
20. DNMT1 Regulates Epithelial-Mesenchymal Transition and Cancer Stem Cells, Which Promotes Prostate Cancer Metastasis.
Lee E; Wang J; Yumoto K; Jung Y; Cackowski FC; Decker AM; Li Y; Franceschi RT; Pienta KJ; Taichman RS
Neoplasia; 2016 Sep; 18(9):553-66. PubMed ID: 27659015
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]